Author

Jinkun Zhang 1

1 Arena Pharmaceuticals,San Diego,United States

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A SELECTIVE, ORAL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD (APD334), IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE OASIS STUDY

William Sandborn, Laurent Peyrin-Biroulet, Luba Trokan, Jinkun Zhang, Tanja Kühbacher, Michael Chiorean, Scott D. Lee, Severine Vermeire, Bruce Yacyshyn, Snehal U. Naik, Preston Klassen, Julian Panés

Long-term efficacy and safety of etrasimod for ulcerative colitis: results from the open-label extension of the OASIS study

Severine Vermeire, Julian Panés, Michael Chiorean, Laurent Peyrin-Biroulet, Jinkun Zhang, Bruce E. Sands, Krisztina Lazin, Chris Cabell, Snehal U. Naik, Preston Klassen, William Sandborn

Item 1 - 2 / 2
1